Tim Ackerman - Swedencare Managing Inc
| SWDCF Stock | USD 3.87 0.27 7.50% |
Insider
Tim Ackerman is Managing Inc of Swedencare AB
| Phone | 46 04 08 59 33 |
| Web | https://www.swedencare.se |
Swedencare Management Efficiency
Swedencare's management efficiency ratios could be used to measure how well Swedencare manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Benjamin Vega | Glass House Brands | N/A | |
| Francesca Brooks | Glass House Brands | N/A | |
| Sue Baker | Allergy Therapeutics plc | N/A | |
| Dietrich Stber | Basilea Pharmaceutica AG | N/A | |
| Matthew Heath | Allergy Therapeutics plc | N/A | |
| Sophy Abraham | Elite Pharma | N/A | |
| Ursula Eberhardt | Basilea Pharmaceutica AG | 61 | |
| Ying MBA | Viva Biotech Holdings | 60 | |
| Simon Piggott | Allergy Therapeutics plc | N/A | |
| Lutz Wevelsiep | Basilea Pharmaceutica AG | N/A | |
| Marc MD | Basilea Pharmaceutica AG | 59 | |
| Jianhua Cai | Viva Biotech Holdings | N/A | |
| Han Dai | Viva Biotech Holdings | 43 | |
| JD MBA | Elite Pharma | N/A | |
| Monica Benyk | PolyNovo Limited | N/A | |
| Beverly Lees | Allergy Therapeutics plc | N/A | |
| Hilal Tabsh | Glass House Brands | N/A | |
| JanMarcel CA | PolyNovo Limited | N/A | |
| Damian Heller | Basilea Pharmaceutica AG | 57 | |
| Murray Skinner | Allergy Therapeutics plc | N/A | |
| Alan Bullimore | Allergy Therapeutics plc | N/A | |
Management Performance
| Return On Equity | 0.0284 | |||
| Return On Asset | 0.0081 |
Swedencare AB Leadership Team
Elected by the shareholders, the Swedencare's board of directors comprises two types of representatives: Swedencare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Swedencare. The board's role is to monitor Swedencare's management team and ensure that shareholders' interests are well served. Swedencare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Swedencare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sabine Uhde, Head AB | ||
| Hans Persson, Managing Buccosant | ||
| Raquel Tosca, Country Mang | ||
| Edward Holden, Managing LLC | ||
| Tim Ackerman, Managing Inc | ||
| Jenny Graflind, Chief Officer | ||
| Ioanna Psychogiou, Managing IKE | ||
| Hakan Lagerberg, Chief Officer | ||
| John Leonard, Managing Ltd | ||
| Matthew Shaw, Managing Ltd |
Swedencare Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Swedencare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0284 | |||
| Return On Asset | 0.0081 | |||
| Profit Margin | 0.09 % | |||
| Current Valuation | 793.04 M | |||
| Shares Outstanding | 158.73 M | |||
| Shares Owned By Insiders | 63.52 % | |||
| Shares Owned By Institutions | 24.78 % | |||
| Price To Earning | 55.56 X | |||
| Price To Book | 0.71 X | |||
| Price To Sales | 3.57 X |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Swedencare OTC Stock
Swedencare financial ratios help investors to determine whether Swedencare OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Swedencare with respect to the benefits of owning Swedencare security.